Asthma Clinical Trials in Huntington Beach, California

4 studies are recruiting for asthma in Huntington Beach, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

    The primary purpose of this study is to evaluate the effects of Fluticasone Furoate (FF)/ Umeclidinium (UMEC)/ Vilanterol (VI) on lung function compared with FF/VI after 24 weeks of treatment.

    Stage
    Phase 3
    Ages
    12 to 17
    Site
    GSK Investigational Site, Huntington Beach, California
    Locations
    67 in total
    Run by
    GlaxoSmithKline

    See if you can join NCT05757102 on ClinicalTrials.gov

  2. A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

    The primary objective of the trial is to evaluate the efficacy of fluticasone propionate/albuterol sulfate multidose dry powder inhaler with electronic module (Fp/ABS eMDPI). Secondary objectives are: * To evaluate the efficacy of Fp/ABS eMDPI administered four times daily * To evaluate the safety …

    Stage
    Phase 3
    Ages
    12 and older
    Site
    Teva Investigational Site 12103, Huntington Beach, California
    Locations
    189 in total
    Run by
    Teva Branded Pharmaceutical Products R&D LLC

    See if you can join NCT06664619 on ClinicalTrials.gov

  3. Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

    The purpose of this study is to compare the effect of budesonide/albuterol metered-dose inhaler (BDA MDI) with albuterol sulfate metered-dose inhaler (AS MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis of a…

    Stage
    Phase 3
    Ages
    12 to 17
    Site
    Research Site, Huntington Beach, California
    Locations
    150 in total
    Run by
    AstraZeneca

    See if you can join NCT06307665 on ClinicalTrials.gov

  4. Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

    This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids.

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Research Site, Huntington Beach, California
    Locations
    221 in total
    Run by
    AstraZeneca

    See if you can join NCT06932263 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.